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ABSTRACT
Objectives: To assess the incidence of cervical intraepithelial neoplasia — SIL and cervical cancer in a population of preg-
nant women with an abnormal cytology.
Material and methods: In pregnant women with abnormal cytology results according to The Bethesda System, a verifying 
diagnostics was carried out, including colposcopy and cervical biopsy.
Results: The most common histological and oncologic diagnosis in the whole study group of pregnant women were HGSIL 
changes, covering cervical intraepithelial neoplasia of medium and high grade — CIN 2 and CIN 3.
Conclusions: HGSIL changes are the most common oncological pathology in a population of pregnant women with 
an abnormal cytology. Precise risk identification of HGSIL changes with the use of molecular tests can significantly reduce 
the number of surgical procedures in a population of pregnant patients with a cytological diagnosis of ASCUS and LSIL.
Key words: cervical intraepithelial neoplasia, pregnancy, HGSIL
Ginekologia Polska 2017; 88, 1: 20–23
Corresponding author:
Dominik Pruski
Gynecology and Obstetrics Clinical Hospital
Karol Marcinkowski University of Medical Sciences
Polna St. 33, 60–535 Poznan, Poland
e-mail: dominik.pruski@oxytop.pl
INTRODUCTION
Cervical intraepithelial neoplasia and cervical cancer are 
the most common cytological diagnosis in a population of 
pregnant women, being a worldwide health problem in the 
population [1]. In the United States from 2% to 7% of preg-
nant patients are diagnosed with an abnormal cytological 
result [2, 3]. The most important risk factor for cervical cancer 
and cervical intraepithelial neoplasia — CIN is a persistent 
infection with oncogenic types of human papillomavirus 
— HPV. Despite the decrease of morbidity and mortality due 
to cervical cancer in Poland in the last decade — following 
the introduction of the Ministerial Programme for Preven-
tion of Cervical Cancer, cancer and CIN changes are one of 
the most recognized pathology of cancer in the population 
of pregnant patients [4, 5].
 Verification of an abnormal Pap smear in the popula-
tion of pregnant patients is a difficult issue since it is hard 
to specify algorithms and guidelines. Colposcopic images in 
pregnancy are very difficult to interpret, and thus implying 
a great risk of human error, due to a high level of examina-
tion’s subjectivity [6, 7]. The doctor — a gynecologist often 
reflects on the legitimacy of performing a full diagnosis of the 
treatment — a cervical biopsy and the risk of complications 
of properly developing pregnancy in patients with question-
able cytological diagnosis, assessed by The Bethesda System.
The following statistical analysis of the incidence of 
cervical intraepithelial neoplasia and cervical cancer in spe-
cific diagnoses of an abnormal Pap smear can significantly 
facilitate the development of additional algorithms, which 
will be characterized by a higher sensitivity and specificity 
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to detect this type of pathology, and will be more accepted 
by a pregnant patient.
The aim of the study was the incidence of cervical 
intraepithelial neoplasia — LGSIL (low-grade squamous 
intraepithelial lesion) and HGSIL (high grade squamous 
intraepithelial lesion) and cervical cancer in a population of 
pregnant women with an abnormal pap smear.
MATERIAL AND METHODS
Statistical analysis included 184 pregnant patients at the 
age of 18 to 47, who reported to the Laboratory of Patho-
physiology of Uterine Cervix in Gynaecology and Obstetrics 
Clinical Hospital of Karol Marcinkowski University of Medical 
Sciences, due to an abnormal Pap test assessed according 
to the Bethesda system in 2007–2015.
In all patients, the diagnostics was performed involv-
ing colposcopy and cervical biopsy. The above diagnostic 
treatment was carried out in Gynaecology and Obstetrics 
Clinical Hospital of the University of Medical Sciences. After 
the procedure, the patient remained under 24 hour obser-
vation in the hospital. The indication for cervical biopsy in 
pregnant patients were abnormal cytological diagnosis 
implying oncological pathology according to the Bethesda 
system. Abnormal cytological diagnoses included: ASC-US, 
LSIL, ASC-H, HSIL, AGC, and cancer respectively.
All patients qualified for the study were adults. Each 
patient gave a written consent for the study. Regardless of 
the histopathological result all the patients were informed 
of the need for strict cytological-colposcopic control every 
3 months throughout the pregnancy and the year after 
giving birth, in the Laboratory of Pathophysiology Cervical 
Gynaecology and Obstetrics at the Clinical Hospital of the 
University of Medical Sciences. In case of an abnormal cytol-
ogy, a suspicious colposcopic image or histopathological 
diagnosis of precancerous changes or cancer, further diag-
nostic and therapeutic procedure was carried out.
Statistical analysis was performed using GraphPad InStat 
version 3.10. Fisher’s exact test was used to compare the inci-
dence of specific histopathological diagnoses by age groups 
and the statistical significance was assumed at p < 0.05.
RESULTS
The most common histological and oncologic diagnosis 
in the whole study group of pregnant women were HGSIL 
changes, covering cervical intraepithelial neoplasia of medi-
um and high grade — CIN 2 and CIN 3, which accounted for 
38% (69/184). Pathology of LGSIL type defining low-grade 
cervical intraepithelial neoplasia has been estimated at 15% 
(28/184). In more than 47% (86/184) of patients tested with 
abnormal cytology there was no cervical pathology of cervi-
cal intraepithelial neoplasia and cancer — NILM (no intraepi-
thelial lesion or malignancy) (Fig. 1). Only one patient was 
diagnosed with adenocarcinoma of the cervix, in whom 
surgical conization was performed during pregnancy. The 
patient gave birth to a healthy baby by a caesarean section.
The most common abnormal cytological diagnosis in 
the whole group of pregnant patients was diagnosis of 
LSIL and HSIL, which respectively accounted for 50% and 
30% (Fig. 2).
In case of an abnormal cytology classified as HSIL, ASC-H 
and cytologically suspected cancer there is more than 62% 
risk of histopathological changes of HGSIL type (Fig. 3).
In case of an abnormal Pap smear, assessed as ASCUS 
and LSIL, the probability of not finding changes as precan-
cerous and cancer is over 80% (Fig. 3).
The entire population of pregnant patients with abnor-
mal cytology (n = 184) was divided into three age groups:
 Ū less than 25 years old (n = 41),
 Ū between 26 and 35 years old (n = 121),
 Ū over 36 years old (n = 22).
In the group of patients under 25, LGSIL and HGSIL 
diagnoses accounted for 22% and 24% respectively. How-
ever, in the age group of 26 to 35, LGSIL HGSIL diagnoses 
accounted for 12% and 42% respectively. In the group of 
NILM
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Figure 1. Percentage proportions of all histopathological diagnoses 
in the population of pregnant patients aged from 18 to 47 (n = 184)
Figure 2. The number of individual abnormal cytologic diagnoses in 
the general population of pregnant patients
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the eldest patients histopathological diagnosis of LGSIL 
accounted for 18%, and HGSIL diagnosis together with one 
case of adenocarcinoma accounted for 42% (Fig. 4). A sta-
tistically significant difference (p = 0.0459) was observed in 
the frequency of HGSIL type changes in patients aged less 
than 25, and a group of patients aged 26 to 35.
DISCUSSION
This retrospective analysis confirms a significant drop 
in the incidence of cervical cancer in a population of preg-
nant patients in all age groups in the Wielkopolska Region 
in 2007–2015. The most common oncologic diagnosis in 
the study population of pregnant women are HGSIL type 
changes covering cervical intraepithelial neoplasia of me-
dium and high grade (Fig. 1). The above analysis clearly 
confirms the increase in the incidence of HGSIL type changes 
together with the increasing age of pregnant women, which 
is particularly observed and statistically significant between 
the group of patients under 25 and 26 to 35 years old. Similar 
conclusions can be found in the 2007 Frega and associates, 
where the highest CIN incidence has been observed in the 
age group of 18 to 35 years old [8].
According to the work of Al-Halal of 2012, the incidence 
of cervical intraepithelial neoplasia — CIN covers from 1.3 to 
2.7 of cases per 1.000 pregnant women [9]. According to the 
worldwide literature, HGSIL type changes undergo spon-
taneous regression during confinement depending on the 
publication from 48 to 70% [10, 11].
For many years, doctors have been looking for newer 
more sensitive and specific diagnostic tools to detect cervi-
cal cancer and cervical intraepithelial neoplasia. In times of 
significant decrease of cervical morbidity and moratlity, to 
maintain the trend in the incidence and mortality of cervical 
cancer in Poland and to identify the most important risk fac-
tor for developing this type of cervical pathology — which 
is a persistent infection with oncogenic HPV types, we are 
witnesses of major changes in the preventive programs in 
Western European countries and in the US, and in a moment 
also in Poland. In the near future, a molecular test identifying 
a genetic DNA material or mRNA transcripts of highly onco-
genic types of human papillomavirus can replace cytological 
programs to prevent cervical cancer patients including both 
non-pregnant and pregnant patients [12].
Precise identification of the risk of HGSIL type (CIN 2, 
CIN 3) changes and distinguishing them from LGSIL type 
(CIN 1) changes, using molecular diagnostics might help to 
decrease surgical procedures in the population of pregnant 
women, cytologcially diagnosed with ASCUS ans LSIL. 
The development of recent years is an application of 
tests for mRNA transcripts of oncogenes E6 / E7 — highly 
oncogenic types of human papillomavirus, which allow 
the identification of patients with persistent viral infection, 
in whom the process of incorporation of viral DNA into 
the genetic material of epithelium’s cells has begun. This 
diagnosis is characterized by a very high sensitivity and 
Figure 4. The incidence of histopathologic diagnoses in certain age 
groups
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Figure 3. Percantage proportion of individual abnormal cytological diagnoses in pregnant patients with 
histopathologic diagnosis of HGSIL and adenocarcinoma, LGSIL or negative for intraepithelial lesion or 
malignancy — NILM
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specificity of 98% and 85% respectively and a high level of 
objectivity and study reproducibility in a population of not 
pregnant patients [13]. The method of obtaining material 
for molecular diagnostics is a non-invasive method, which 
does not affect the pregnancy.
In summary, the above retrospective analysis clearly 
indicates the necessity to complement the diagnosis of 
molecular test that detects highly oncogenic types of hu-
man papillomavirus, which allows for more precise identi-
fication of groups at risk of HGSIL type in the population of 
pregnant patients with abnormal cytology of ASCUS or LSIL
CONCLUSIONS
HGSIL changes including cervical intraepithelial neopla-
sia of medium and high grade were the most common on-
cological pathology in the population of pregnant women 
with an abnormal cytology. Precise identification of the 
risk of incidence of HGSIL type changes using molecular 
diagnostic tests can significantly reduce the number of 
surgical procedures in the population of pregnant patients 
with a cytologic diagnosis of ASCUS.
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